Below are the financial statements of Cspc Pharmaceutical Group, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in billions of CNY | 2024 as of 2024-12-31 | 2023 as of 2023-12-31 |
|---|---|---|
| Non-current assets | — | — |
| Property, plant and equipment | 11.37a | 10.42a |
| Right-of-use assets | 1.13a | 1.23a |
| Investment property | 0.06a | 0.06a |
| Goodwill | 0.23a | 0.23a |
| Intangible assets | 2.61a | 2.2a |
| Interests in associates | 0.82a | 0.79a |
| Interests in joint ventures | 0.71a | 0.68a |
| Other financial assets | 2.33a | 2.39a |
| Deferred tax assets | 0.25a | 0.19a |
| Deposits, prepayments and other receivables | 0.58a | 0.62a |
| Bank deposits | 2.41a | 0.74a |
| Current assets | — | — |
| Inventories | 3.13a | 3.14a |
| Trade receivables | 5.16a | 5.87a |
| Deposits, prepayments and other receivables | 0.89a | 0.67a |
| Bills receivables | 4.04a | 3.69a |
| Amounts due from related companies | 0.36a | 0.16a |
| Amounts due from joint ventures | 0.07a | 0.13a |
| Other financial assets | 0.17a | 0a |
| Structured bank deposits | 1.31a | 1.08a |
| Bank deposits, balances and cash | 6.78a | 12.02a |
| Current liabilities | — | — |
| Trade payables | 1.67a | 2.43a |
| Other payables | 5.74a | 5.98a |
| Contract liabilities | 0.28a | 0.33a |
| Bills payables | 0.95a | 0.42a |
| Amounts due to related companies | 0.27a | 0.02a |
| Amounts due to joint ventures | 0.13a | 0.04a |
| Lease liabilities | 0.06a | 0.15a |
| Tax liabilities | 0.14a | 0.38a |
| Bank borrowings | 0.39a | 0.45a |
| Net current assets | 12.25a | 16.56a |
| Total assets less current liabilities | 34.75a | 36.1a |
| Non-current liabilities | — | — |
| Other payables | 0.41a | 0.4a |
| Lease liabilities | 0.06a | 0.11a |
| Deferred tax liabilities | 0.42a | 0.57a |
| Net assets | 33.87a | 35.02a |
| Capital and reserves | — | — |
| Share capital | 11.03a | 10.9a |
| Reserves | 21.23a | 22.3a |
| Equity attributable to owners of the Company | 32.26a | 33.2a |
| Non-controlling interests | 1.6a | 1.81a |
| Total equity | 33.87a | 35.02a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.